Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Claire Leonardi Steps Down as Connecticut Innovations CEO
  • USA - English


News provided by

Connecticut Innovations

Dec 18, 2014, 14:00 ET

Share this article

Share toX

Share this article

Share toX


ROCKY HILL, Conn. (PRWEB) December 18, 2014 -- Leonardi's last day will be January 8, 2015, which will allow her to assist with the transition and help the board name a successor.

Claire’s extraordinary vision and leadership guided CI to its position as one of the most active venture capital investors in the country, and paved the way for outstanding innovations such as the $200 million Connecticut Bioscience Innovation Fund

Post this

“Claire’s extraordinary vision and leadership guided CI to its position as one of the most active venture capital investors in the country, and paved the way for outstanding innovations such as the $200 million Connecticut Bioscience Innovation Fund to help commercialize bioscience discoveries, and new investment programs in collaboration with both UConn and Yale to capitalize on each university’s most promising startups,” said Michael Cantor, chairman of CI’s board and a co-managing partner at Cantor Colburn LLP. “Claire did all this while successfully overseeing a merger, assuming management of Connecticut’s entrepreneurial ecosystem, and establishing a number of highly innovative programs. On behalf of the board, I thank Claire for working closely with us and the Malloy Administration to build a stronger foundation for innovation and growth in Connecticut.”

“It has been a privilege to lead this organization through its transition to a larger, more diverse, highly-visible and impactful participant in Connecticut's economic development landscape,” said Leonardi. “We couldn’t have accomplished what we did without the strong support of the Malloy Administration. From the additional $125 million capital allocation provided by the 2011 Jobs Bill, which was earmarked to support increased investment in high-tech companies, to the sponsorship of the Connecticut Bioscience Innovation Fund as a Governor’s Bill in 2013 to spur commercialization of the exceptional bioscience research being conducted in our state, this administration has stood with us, championing Connecticut’s most innovative entrepreneurs who are doing fascinating, groundbreaking work in our state.”

A Wharton M.B.A., Leonardi is a veteran investment and venture capital executive with more than 30 years of experience in the financial services industry. Prior to joining CI, she advised companies in upstate New York on capital structure and funding, strategic planning and performance improvement. She was a founder of Fairview Capital L.P., and, before that, held senior investment positions at Crossroads Capital, where she managed portfolios for large institutional clients.

In addition to her work experience, Leonardi served as chair of the board of directors of the University of Connecticut Health Center. She also served as vice chair of the UConn Board of Trustees.

Highlights of CI’s accomplishments under Leonardi’s leadership are numerous, and include:
• Dramatically increased venture capital investments, more than doubling CI’s annual investment and tripling the number of portfolio companies, which now exceeds 100. CI is now one of the most active early-stage investors in the country with a particular strength in bioscience.
• Completed a merger with the Connecticut Development Authority (CDA), including integration of programs, finances and staff.
• Developed and launched the $200 million Connecticut Bioscience Innovation Fund, now a major driver of collaboration and commercialization.
• Refined the pre-seed program to better align with the venture program, enabling it to become CI’s strongest pipeline for new, high-quality deals.
• Rebranded and enhanced the perception and image of CI in the marketplace with a new logo and tagline, new collateral, an award-winning website, a new content marketing strategy, a ramped up social media presence, and a dedicated, customer-focused intake specialist.
• On-boarded and consolidated the stem cell research program into CI, broadening its mandate to include regenerative medicine and enhancing processes to increase effectiveness.
• Introduced a bioscience-focused website to better serve customers and highlight this important segment.
• Developed close partnerships with the state's two research universities, including the Yale Innovation Fund partnership with Yale and First Niagara Bank; the Third Bridge Partnership to help UConn students spin out companies from the School of Engineering; collaboration on the recent REACH grant submission, including both UConn and Yale; and focused outreach such as holding office hours at the universities with our SBIR, CBIF and venture managers.
• Introduced additional services to assist portfolio companies, including office hours for marketing help (branding, PR, website maximization); an executive-in-residence to provide strategic, hands-on assistance with product ramp-up, cash flow management and general mentoring; a jobs board for startups to promote open positions and internship opportunities, a STEM internship grant program to assist in hiring and retaining Connecticut graduates, and a focus on strategic partnerships, helping companies connect with customers, suppliers, academics and service providers.
• Brought CTNext (Connecticut’s entrepreneurial ecosystem) in-house, providing more focus, emphasizing outcomes and integrating it into CI’s work with the entrepreneurial community.
• Launched the Entrepreneur Innovation Awards, a competitive pitch event that provides small grants to help companies propel to the next level.
• Developed a focused effort in lending, transitioning the old CDA from the lender of last resort to a valued partner of private sector banks.
• From an operational standpoint, strengthened team, updated policies and processes, and implemented technology solutions to better serve customers and accommodate the increase in scale and product breadth.

The board will announce Leonardi’s successor in the coming weeks.

About Connecticut Innovations Inc.
Connecticut Innovations (CI) is the leading source of financing and ongoing support for Connecticut's innovative, growing companies. To maximize the growth potential of each business, CI tailors its solutions and often combines its funds with resources from other financial leaders to provide venture capital and strategic support for early-stage technology companies; flexible loans for established companies with new innovations; grants that support innovation and collaboration; and connections to its well-established network of partners and professionals. Through all these initiatives, CI has helped bring $4 billion in financing to Connecticut companies. The state’s most active early-stage investor, CI has created more than 26,000 jobs. For more information on CI, please visit http://www.ctinnovations.com.

Kelsea Michael, Connecticut Innovations, http://ctinnovations.com/, +1 (646) 266-1559, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.